WELLS FARGO & COMPANY/MN - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 118 filers reported holding KURA ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$545,767
-11.8%
59,843
+2.4%
0.00%
Q2 2023$618,475
-31.3%
58,457
-20.6%
0.00%
Q1 2023$900,507
+324.9%
73,631
+331.2%
0.00%
Q4 2022$211,913
-25.4%
17,076
-18.0%
0.00%
Q3 2022$284,000
-29.4%
20,825
-4.9%
0.00%
Q2 2022$402,000
-12.2%
21,898
-23.1%
0.00%
Q1 2022$458,000
-31.3%
28,470
-40.2%
0.00%
Q4 2021$667,000
-7.6%
47,603
+23.4%
0.00%
Q3 2021$722,000
-17.3%
38,573
-7.8%
0.00%
Q2 2021$873,000
-70.9%
41,826
-60.6%
0.00%
-100.0%
Q1 2021$3,002,000
-46.2%
106,193
-37.9%
0.00%0.0%
Q4 2020$5,584,000
+249.7%
170,972
+227.9%
0.00%
Q3 2020$1,597,000
+86.1%
52,136
-0.9%
0.00%
Q2 2020$858,000
+117.8%
52,613
+32.8%
0.00%
Q1 2020$394,000
-46.2%
39,605
-25.8%
0.00%
Q4 2019$733,000
+15.1%
53,367
+27.1%
0.00%
Q3 2019$637,000
-23.7%
41,984
-1.1%
0.00%
Q2 2019$835,000
+22.4%
42,448
+3.3%
0.00%
Q1 2019$682,000
+40.6%
41,102
+19.1%
0.00%
Q4 2018$485,000
-34.4%
34,521
-18.2%
0.00%
Q3 2018$739,000
+41.3%
42,222
+46.9%
0.00%
Q2 2018$523,000
-53.1%
28,733
-51.7%
0.00%
Q1 2018$1,115,000
+107.6%
59,448
+69.3%
0.00%
Q4 2017$537,000
+471.3%
35,105
+454.8%
0.00%
Q3 2017$94,0006,3280.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2018
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders